Quality of life in ICON7: need for patients' perspectives.
Publication
, Journal Article
Havrilesky, LJ; Abernethy, AP
Published in: Lancet Oncol
March 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
March 2013
Volume
14
Issue
3
Start / End Page
183 / 185
Location
England
Related Subject Headings
- Ovarian Neoplasms
- Oncology & Carcinogenesis
- Humans
- Female
- Drug-Related Side Effects and Adverse Reactions
- Bevacizumab
- Antineoplastic Combined Chemotherapy Protocols
- Antibodies, Monoclonal, Humanized
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Havrilesky, L. J., & Abernethy, A. P. (2013). Quality of life in ICON7: need for patients' perspectives. Lancet Oncol, 14(3), 183–185. https://doi.org/10.1016/S1470-2045(12)70590-9
Havrilesky, Laura J., and Amy P. Abernethy. “Quality of life in ICON7: need for patients' perspectives.” Lancet Oncol 14, no. 3 (March 2013): 183–85. https://doi.org/10.1016/S1470-2045(12)70590-9.
Havrilesky LJ, Abernethy AP. Quality of life in ICON7: need for patients' perspectives. Lancet Oncol. 2013 Mar;14(3):183–5.
Havrilesky, Laura J., and Amy P. Abernethy. “Quality of life in ICON7: need for patients' perspectives.” Lancet Oncol, vol. 14, no. 3, Mar. 2013, pp. 183–85. Pubmed, doi:10.1016/S1470-2045(12)70590-9.
Havrilesky LJ, Abernethy AP. Quality of life in ICON7: need for patients' perspectives. Lancet Oncol. 2013 Mar;14(3):183–185.
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
March 2013
Volume
14
Issue
3
Start / End Page
183 / 185
Location
England
Related Subject Headings
- Ovarian Neoplasms
- Oncology & Carcinogenesis
- Humans
- Female
- Drug-Related Side Effects and Adverse Reactions
- Bevacizumab
- Antineoplastic Combined Chemotherapy Protocols
- Antibodies, Monoclonal, Humanized
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis